These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Inhibition of dengue virus by novel, modified antisense oligonucleotides. Raviprakash K; Liu K; Matteucci M; Wagner R; Riffenburgh R; Carl M J Virol; 1995 Jan; 69(1):69-74. PubMed ID: 7983769 [TBL] [Abstract][Full Text] [Related]
24. Antisense oligonucleotides directed against p53 have antiproliferative effects unrelated to effects on p53 expression. Barton CM; Lemoine NR Br J Cancer; 1995 Mar; 71(3):429-37. PubMed ID: 7880719 [TBL] [Abstract][Full Text] [Related]
25. Antiviral activity and protection of cells against human immunodeficiency virus type-1 using an antisense oligodeoxyribonucleotide phosphorothioate complementary to the 5'-LTR region of the viral genome. Anazodo MI; Salomon H; Friesen AD; Wainberg MA; Wright JA Gene; 1995 Dec; 166(2):227-32. PubMed ID: 8543166 [TBL] [Abstract][Full Text] [Related]
26. Antisense phosphorothioate oligodeoxynucleotides alter HIV type 1 replication in cultured human macrophages and peripheral blood mononuclear cells. Weichold FF; Lisziewicz J; Zeman RA; Nerurkar LS; Agrawal S; Reitz MS; Gallo RC AIDS Res Hum Retroviruses; 1995 Jul; 11(7):863-7. PubMed ID: 7546914 [TBL] [Abstract][Full Text] [Related]
27. Inhibition of replication of drug-resistant HIV type 1 isolates by polypurine tract-specific oligodeoxynucleotide TFO A. Jendis J; Strack B; Moelling K AIDS Res Hum Retroviruses; 1998 Jul; 14(11):999-1005. PubMed ID: 9686646 [TBL] [Abstract][Full Text] [Related]
28. Antisense oligodeoxynucleotide: inhibitor of splicing of mRNA of human immunodeficiency virus. Daum T; Engels JW; Mag M; Muth J; Lücking S; Schröder HC; Matthes E; Müller WE Intervirology; 1992; 33(2):65-75. PubMed ID: 1568836 [TBL] [Abstract][Full Text] [Related]
29. Is antisense an appropriate nomenclature or design for oligodeoxynucleotides aimed at the inhibition of HIV-1 replication? Lavigne C; Yelle J; Sauve G; Thierry AR AAPS PharmSci; 2002; 4(2):E9. PubMed ID: 12102618 [TBL] [Abstract][Full Text] [Related]
30. Antisense phosphorothioate oligonucleotide inhibits interleukin 1 beta production in the human macrophage-like cell line, U937. Yahata N; Kawai S; Higaki M; Mizushima Y Antisense Nucleic Acid Drug Dev; 1996; 6(1):55-61. PubMed ID: 8783796 [TBL] [Abstract][Full Text] [Related]
31. Inhibition of human immunodeficiency virus type 1 activity in vitro by oligonucleotides composed entirely of guanosine and thymidine. Ojwang J; Elbaggari A; Marshall HB; Jayaraman K; McGrath MS; Rando RF J Acquir Immune Defic Syndr (1988); 1994 Jun; 7(6):560-70. PubMed ID: 7513761 [TBL] [Abstract][Full Text] [Related]
32. Inhibition of hepatitis C virus replication by antisense oligonucleotide in culture cells. Mizutani T; Kato N; Hirota M; Sugiyama K; Murakami A; Shimotohno K Biochem Biophys Res Commun; 1995 Jul; 212(3):906-11. PubMed ID: 7626129 [TBL] [Abstract][Full Text] [Related]
33. Inhibition of human immunodeficiency virus type 1 activity in vitro by a new self-stabilized oligonucleotide with guanosine-thymidine quadruplex motifs. Suzuki J; Miyano-Kurosaki N; Kuwasaki T; Takeuchi H; Kawai G; Takaku H J Virol; 2002 Mar; 76(6):3015-22. PubMed ID: 11861867 [TBL] [Abstract][Full Text] [Related]
34. The influence of target protein half-life on the effectiveness of antisense oligonucleotide analog-mediated biologic responses. Spiller DG; Giles RV; Broughton CM; Grzybowski J; Ruddell CJ; Tidd DM; Clark RE Antisense Nucleic Acid Drug Dev; 1998 Aug; 8(4):281-93. PubMed ID: 9743466 [TBL] [Abstract][Full Text] [Related]
35. Antisense phosphorothioate oligodeoxynucleotides targeted to the vpr gene inhibit human immunodeficiency virus type 1 replication in primary human macrophages. Balotta C; Lusso P; Crowley R; Gallo RC; Franchini G J Virol; 1993 Jul; 67(7):4409-14. PubMed ID: 8510229 [TBL] [Abstract][Full Text] [Related]
36. Differential regulation of CXCR4 and CCR5 expression by interleukin (IL)-4 and IL-13 is associated with inhibition of chemotaxis and human immunodeficiency Virus (HIV) type 1 replication but not HIV entry into human monocytes. Creery D; Weiss W; Graziani-Bowering G; Kumar R; Aziz Z; Angel JB; Kumar A Viral Immunol; 2006; 19(3):409-23. PubMed ID: 16987060 [TBL] [Abstract][Full Text] [Related]
37. Inhibition of HIV-1 in cell culture by oligonucleotide-loaded nanoparticles. Berton M; Turelli P; Trono D; Stein CA; Allémann E; Gurny R Pharm Res; 2001 Aug; 18(8):1096-101. PubMed ID: 11587479 [TBL] [Abstract][Full Text] [Related]
38. Regulation of viral expression of human immunodeficiency virus in vitro by an antisense phosphorothioate oligodeoxynucleotide against rev (art/trs) in chronically infected cells. Matsukura M; Zon G; Shinozuka K; Robert-Guroff M; Shimada T; Stein CA; Mitsuya H; Wong-Staal F; Cohen JS; Broder S Proc Natl Acad Sci U S A; 1989 Jun; 86(11):4244-8. PubMed ID: 2471199 [TBL] [Abstract][Full Text] [Related]
39. Enhanced antisense inhibition of human immunodeficiency virus type 1 in cell cultures by DLS delivery system. Lavigne C; Thierry AR Biochem Biophys Res Commun; 1997 Aug; 237(3):566-71. PubMed ID: 9299405 [TBL] [Abstract][Full Text] [Related]
40. Inhibition of human immunodeficiency virus type 1 replication by P-stereodefined oligo(nucleoside phosphorothioate)s in a long-term infection model. Inagawa T; Nakashima H; Karwowski B; Guga P; Stec WJ; Takeuchi H; Takaku H FEBS Lett; 2002 Sep; 528(1-3):48-52. PubMed ID: 12297278 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]